Proactively
Detect Pathogenic Activity
Based on in vitro testing, WoundCue™ can empower clinicians and caregivers with timely, actionable visual evidence of rising wound infection risk—signaling, through a color change at critical thresholds of pathogen presence, when proactive intervention is needed. No culturing, devices, or batteries will be required!
Our Partners
WoundCue™ Detection
WoundCue™ is a nanofiber membrane that reactively changes color at critical thresholds of bacterial or fungal presence, in-vitro - which would allow clinicians and caregivers to intervene earlier.
Why It Matters
WoundCue™ will be a smarter way to manage wounds. It could empower earlier interventions, better outcomes, and greater peace of mind for clinicians, caregivers, and patients.
01
Potential for seamless integration with existing wound care protocols
02
Visual indication of pathogenic activity before symptoms or complications arise, based on in-vitro testing.
03
No connectivity required. Just place and observe — our goal is to be visible, reliable, intuitive and usable across all care settings including rural and austere environments.
04
User-friendly and will require minimal training. Design will be suitable for use by caregivers, patients, and healthcare providers of all skill levels—even those with no prior experience.
05
Will provide continuous monitoring to indicate the need for intervention as early as possible.
“Good wound care should be directed care. Diagnostic tools direct that care. The WoundCue will have the capability to do that; It could direct the clinician, at the point of care, to take appropriate steps in a timely fashion for better outcomes.”
Ronald Scott
Wound Care Advisor - MD
What We're Fighting
01
Fighting Harmful Pathogens
Pathogens like Staphylococcus aureus, Pseudomonas aeruginosa, Candida auris and other bacteria and fungal strains can silently escalate wound severity. Based on in-vitro testing, WoundCue™ signals when pathogenic activity increases.
02
Preventing Complications Before They Start
Untreated pathogenic growth contributes to infection, biofilm formation, delayed healing, and potential hospitalization. Detecting this change early can support better outcomes.
03
Protecting Patients and Care Teams
WoundCue™ could empower clinicians, caregivers, and patients to intervene sooner — which could reduce uncertainty, improve peace of mind, and support science-driven wound management.
Our Team
We are the leaders in the wound care space. We care about our projects more than you know. We are proud to be apart of this family. Let's do this wonderful thing together.
Chelsea Luxen
CEO, Founder
Maurice Haff
CTO & Co-founder
Peter Rock
Chief Operating OfficerAt ParaNano, we're pioneering the future of smart wound care. Our work is rooted in innovation, compassion, and a deep commitment to patient outcomes. Join us as we share updates, breakthroughs, and the journey toward a healthier tomorrow—together.
© ParaNano.